Literature DB >> 19938034

Special issue: nephrogenic systemic fibrosis.

Tim Leiner1, Walter Kucharczyk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19938034     DOI： 10.1002/jmri.21985

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN： 1053-1807            Impact factor:   4.813


× No keyword cloud information.
  4 in total

Review 1.  Alternatives to gadolinium-based metal chelates for magnetic resonance imaging.

Authors:  Subha Viswanathan; Zoltan Kovacs; Kayla N Green; S James Ratnakar; A Dean Sherry
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

2.  Advancing pharmacovigilance through academic-legal collaboration: the case of gadolinium-based contrast agents and nephrogenic systemic fibrosis-a Research on Adverse Drug Events and Reports (RADAR) report.

Authors:  B J Edwards; A E Laumann; B Nardone; F H Miller; J Restaino; D W Raisch; J M McKoy; J A Hammel; K Bhatt; K Bauer; A T Samaras; M J Fisher; C Bull; E Saddleton; S M Belknap; H S Thomsen; E Kanal; S E Cowper; A K Abu Alfa; D P West
Journal:  Br J Radiol       Date:  2014-10       Impact factor: 3.039

Review 3.  Molecular imaging and targeted therapies.

Authors:  David L Morse; Robert J Gillies
Journal:  Biochem Pharmacol       Date:  2010-04-21       Impact factor: 5.858

4.  Tissue gadolinium deposition in hepatorenally impaired rats exposed to Gd-EOB-DTPA: evaluation with inductively coupled plasma mass spectrometry (ICP-MS).

Authors:  Tomohiro Sato; Tsutomu Tamada; Shigeru Watanabe; Hirotake Nishimura; Akihiko Kanki; Yasufumi Noda; Atsushi Higaki; Akira Yamamoto; Katsuyoshi Ito
Journal:  Radiol Med       Date:  2015-01-09       Impact factor: 3.469
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.